GlobeNewswire by notified

American Humane Awards Dr. Jon Paul Rodríguez, Chair of the IUCN Species Survival Commission, with the Wolfgang Kiessling International Prize for Species Conservation


WASHINGTON, June 21, 2022 (GLOBE NEWSWIRE) -- American Humane, the country’s first national humane organization and the world’s largest certifier of animal welfare practices, today announced that Dr. Jon Paul Rodríguez, Chair of the IUCN Species Survival Commission, is the recipient of the inaugural Wolfgang Kiessling International Prize for Species Conservation. The “Kiessling Prize,” created in honor of Wolfgang F. Kiessling, the founder of Loro Parque and globally acknowledged leader in the conservation space, recognizes those who achieve significant positive change in the field of conservation practice, theory and research.

“American Humane is thrilled to establish the Kiessling Prize – honoring those who are leading the way in the field of conservation,” said Dr. Robin Ganzert, president and CEO of American Humane. “This year’s recipient, Dr. Rodríguez, has made tangible, demonstrable contributions to saving the world’s magnificent animals and is a valiant advocate for good zoos and aquariums who are on the frontlines working to save species on the brink of disappearing forever. We are honored to bestow upon him this prestigious award.”

As the world’s animals face what scientists call a “Sixth Mass Extinction,” with up to one million species in foreseeable danger of disappearing forever, extraordinary efforts to preserve the creatures of the Earth are more vital than ever – as are the scientists, researchers and advocates who devote their lives to these efforts. The Kiessling Prize will be awarded annually to recognize individuals who embody Mr. Kiessling’s exceptional leadership, vision and commitment to conservation and the critical role that zoos and aquariums play.

Dr. Rodríguez was selected from a pool of dozens of candidates representing 16 countries across five continents who lead conservation projects that span the globe in virtually every aspect of conservation – including threat analysis, habitat restoration, genomics, species reintroduction, technology and innovation, and community-based solutions. Dr. Rodríguez has an undergraduate degree in biology from Universidad Central de Venezuela, a PhD in ecology and evolutionary biology from Princeton University, and a Certificate in science, technology and environmental policy from the Woodrow Wilson School of Public and International Affairs at Princeton University. He chairs the IUCN Species Survival Commission, is a professor at the Center for Ecology of the Venezuelan Institute for Scientific Investigations, and is a founder, past board member and president of Provita.

“There is simply no higher purpose than that to protect and preserve our world’s most precious asset – animal life,” said Wolfgang Kiessling, president and founder of Loro Parque and Loro Parque Foundation. “We are grateful to Dr. Rodríguez for dedicating his life to animal conservation.”

The Wolfgang Kiessling International Prize committee is led by Wolfgang Kiessling, Christoph Kiessling, Cybell Kiessling, Dr. Javier Almunia, Dr. Robin Ganzert and Brad Andrews. The committee screened all applicants, ultimately choosing Dr. Rodríguez to be awarded the Kiessling Prize and a grant of US $80,000 to further his work to make significant contributions to the practical application, research and theory of species protection. He will be recognized at the 2022 Kiessling Prize Awards Gala on Friday, June 24 in Washington.

American Humane is the country’s first national humane organization and the world’s largest certifier of animal welfare, overseeing the humane treatment of more than one billion animals across the globe each year. Founded in 1877, American Humane has been First to Serve™ the cause of animals and for 145 years has been at the forefront of virtually every major advance in the humane movement. For more information or to support our lifesaving work, please visit, follow us on FacebookTwitter and Instagram and subscribe to our channel on YouTube for the latest breaking news and features about the animals with whom we share our Earth.

Media Contact
Savannah Young

A photo accompanying this announcement is available at

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Huhtamaki publishes 2022 Half-yearly Report on July 21, 202230.6.2022 09:00:00 CEST | Press release

HUHTAMÄKI OYJ PRESS RELEASE 30.6.2022 AT 10:00 Huhtamaki publishes 2022 Half-yearly Reporton July21, 2022 Huhtamäki Oyj will publish its 2022 Half-yearly Report on Thursday, July 21, 2022, approximately at 8.30 am Finnish time (EEST). The release and related results presentation material will be available after publishing at Teleconference Huhtamaki will arrange a combined audiocast and teleconference on the same day at 9.30 am Finnish time, where the company’s management will present the results. The event will be followed by a Q&A session. The event will be held in English, it can be followed real-time at: If you wish to ask questions, please dial one of the following numbers 5-10 minutes prior to the call start: Finland Toll: +358981710310 Sweden Toll: +46 856642651 United Kingdom Toll: +44 3333000804 United States Toll: +1 6319131422 Confirmation code for the call is 23337170# An on-demand replay of the audiocast w

Fingerprints announces design win for its optical under-display solution with major Asian smartphone OEM30.6.2022 08:00:00 CEST | Press release

Fingerprint Cards AB (Fingerprints™) today announced that it has secured a design win* for its optical under-display solution, FPC 1632, with a major Asian smartphone OEM, following successful qualification tests earlier this year. We expect to commence shipments during the fourth quarter of 2022. “Since many years, Fingerprints is a well-established world leader in capacitive fingerprint sensors. The design win we are announcing today marks our entry into a new market segment: optical under-display fingerprint sensors. This will open up attractive new growth opportunities for us going forward, and our goal is to capture a significant share of this market,” says Ted Hansson, President Mobile, PC & Access China at Fingerprints. For more information about Fingerprints’ mobile device solutions, visit the website. * Fingerprints’ definition of Design Win (DW): The decision by a device vendor (OEM or ODM) to start development of one or several commercial product(s) incorporating Fingerprint

Inaugural Yara Clean Ammonia Capital Markets Day30.6.2022 08:00:00 CEST | Press release

Oslo, 30 June 2022: Today, Yara International ASA (“Yara”) will host a Capital Markets Day (“CMD”) for Yara Clean Ammonia (“YCA” or the “Company”). During the event, members of YCA’s management team will present key features of the Company, including its strategy and growth ambitions, as well as financial parameters and targets for the future. In May 2022, Yara announced that it is evaluating a potential initial public offering (“IPO”) of YCA on the Oslo Stock Exchange. “While the decision to list YCA will be made in due course, Yara is now excited to host an inaugural CMD for YCA to showcase their exciting story,” said Svein Tore Holsether, CEO and President of Yara. “YCA combines a leading midstream business with exceptional growth prospects and a value creating project portfolio.” Key highlights: Clean ammonia represents a massive opportunity that is projected to drive exponential, long-term market growth [1].YCA comprises existing cash flows from a market leading position [2] in a

Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial of UV1 in Malignant Melanoma30.6.2022 08:00:00 CEST | Press release

Full recruitment of 154 patients with malignant melanoma in U.S. and Europe in 24 monthsStudy provides randomized data on impact of UV1 on standard-of-care immunotherapy Topline progression-free survival data expected H1 2023 Oslo, 30 June 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces the completed recruitment of 154 patients in the INITIUM trial. INITIUM is Ultimovacs’ Phase II clinical trial of its universal cancer vaccine UV1 in combination with the checkpoint inhibitors ipilimumab and nivolumab in metastatic malignant melanoma. Consistent with INITIUM’s event-driven design, topline progression-free survival results will be disclosed after progression of cancer or death has been observed in a total of 70 patients. “It is a remarkable achievement that Ultimovacs and its clinical partners have completed recruitment to INITIUM largely on schedule despite challenges caused by the pandemic,” said Carlos de Sou